T he zinc finger transcription factor Gli3 participates in Hedgehog (Hh) signal mediation in mammals. It contains both a weak C-terminal transactivation domain and an N-terminal repressor domain. 1 The role and expression pattern of Gli3 during development have been widely studied, 2, 3 particularly during neural development. The balance between Sonic hedgehog (Shh) and Gli3 expression regulates normal brain patterning: Gli3 promotes differentiation into dorsal cell types, whereas Shh promotes the expression of ventral-cell markers. 4, 5 Gli3 and Shh have been shown to regulate limb skeletal development and digit number 6, 7 in a similar manner, and Gli3 also appears to be involved, to a lesser extent, in lung 8 and kidney 9 development and in somite specification. 10 Although Gli3 antagonizes many of the effects of Shh, 11 it also activates Gli1 transcription in fibroblasts after Shh treatment, 12 thereby contributing positively to Hh-signal transduction. Moreover, Gli3 can function as an Shhindependent transcriptional activator during vertebrate limbdigit patterning. 13, 14 In humans, mutations in Gli3 have been associated with several diseases, including Greig cephalopolysyndactyly syndrome 15 and Pallister-Hall syndrome. 16 During the last few years, we have shown that the Hh pathway is reactivated by ischemia in adult cardiovascular tissue 17 and that Shh, when administered either as recombinant protein or via gene therapy, enhances the neovascularization of ischemic tissue by promoting both angiogenesis 18 and the recruitment of endothelial progenitor cells. 19, 20 Very recently, we have demonstrated that Gli2 and Gli3 are upregulated in ischemic limb muscle and may participate in tissue repair, including myogenesis and angiogenesis. 21 Gli3 is expressed by endothelial cells (ECs) and promotes EC migration and survival in vitro. 21 In vivo, administration of an adenovirus encoding Gli3 increased capillary density and promoted superficial limb perfusion in an animal model of hindlimb ischemia (HLI). 21 After considering these observations, we hypothesized that Gli3 plays a role in ischemiainduced angiogenesis and performed a series of studies to further characterize the role of Gli3 during angiogenesis and ischemic tissue repair.
Methods

Mice
C3HeB/FeJ-Mc1r E-so Gli3 Xt-J /J mice (Gli3 ϩ/Ϫ mice) were bred with C3HeB/FeJ mice; both mouse strains were obtained from The Jackson Laboratories (Bar Harbor, Me). In vivo experiments were performed with Gli3 ϩ/Ϫ mice and their wild-type (WT) littermates. Mice were handled in accordance with the guidelines of the Institutional Animal Care and Use Committee at Northwestern University.
Blood Pressure Measurement
Blood pressure measurements were performed in pretrained, conscious mice via the tail-cuff method (CODA 6 system, Kent Scientific Corporation, Torrington, Conn).
Myocardial Infarction Model and Assessments
Myocardial infarction (MI) was induced in 10-to 12-week-old Gli3 ϩ/Ϫ female mice and their WT littermates (8 to 9 animals/ group). Left ventricular (LV) ejection fractions were measured echocardiographically 7Ϯ1, 14Ϯ1, and 28Ϯ2 days after MI. Fibrosis and capillary density were evaluated in hearts from mice euthanized on day 28; fibrosis was reported as the ratio of the length of fibrosis to the LV circumference. Capillaries were identified by positive staining for CD31. Surgical, echocardiographic, and histological protocols are summarized in the Online Data Supplement, available at http://circres.ahajournals.org.
HLI Model and Assessments
HLI was performed as previously described 22 in 8-week-old male mice (5 to 9 animals/group). Capillary density and the number of smooth muscle-containing vessels were evaluated in sections of tibialis anterior muscles stained for the expression of CD31 and smooth muscle ␣-actin (␣SMA). Surgical and histological protocols are summarized in the Online Data Supplement.
Corneal Angiogenesis Assay
Pellets containing vascular endothelial growth factor (VEGF) or PBS were implanted in the corneas of 6-to 8-week-old female mice as previously described. 23 Eight days later, mice were injected with 50 L of fluorescien-BS1-Lectin I (Vector Laboratories, Burlingame, Calif) 15 minutes before euthanasia. Angiogenesis was quantified by analyzing BS1-Lectin I fluorescence as described previously. 24 Pellet preparation and the surgical and histological protocols are summarized in the Online Data Supplement.
Cell Maintenance and Transfection/Transduction
Human umbilical vein endothelial cells (HUVECs) (Cambrex Corporation, East Rutherford, NJ) and MS1 cells (CRL-2279; American Type Culture Collection, Manassas, Va) were maintained and transfected/transduced as described in the Online Data Supplement; cell assays were performed 48 to 72 hours after transfection/ transduction. The adenovirus encoding ␤-galactosidase and green fluorescent protein (GFP) (Ad-LacZ) was kindly provided by Dr A. Rosenzweig, 25 the adenovirus encoding human Gli3 (Ad-Gli3) was kindly provided by Dr C. M. Fan, 25 and the adenovirus encoding a dominant-negative mutant of Akt (DN-Akt) was kindly provided by Ken Walsh. 26 Human Gli3 small interfering (si)RNA was purchased from Santa Cruz Biotechnology Inc, and non-Gli3-silencing GFP siRNA (5Ј-GGCUACGUCCAGGAGCGCAdTdT-3Ј) was purchased from Dharmacon Inc (Lafayette, Colo). The Gli-BSluciferase, mutant-Gli-luciferase, and pcDNA3.1-His-human Gli3 plasmids were kindly provided by Dr H. Sasaki. 1, 27 Luciferase was assayed with a luciferase assay system (Promega Corporation, Madison, Wis), and ␤-galactosidase activity was assayed as previously described. 28 For each sample, luciferase activity was normalized to ␤-galactosidase activity to compensate for differences in transfection efficiency. Each condition was assayed in triplicate, and each experiment was performed at least three times.
Western Blot
Akt and extracellular signal-regulated kinase (ERK)1/2 phosphorylation was evaluated by SDS-PAGE with anti-Akt, anti-phosphoAkt, anti-p42-p44, and anti-phospho-p42-p44 antibodies (Cell Signaling Technology Inc, Danvers, Mass).
Quantitative RT-PCR and Microarray Analyses
Quantitative RT-PCR was performed with RNA isolated from 3ϫ10 5 cells or from homogenized skeletal or cardiac muscle; RNA microarray analyses were performed with 3 g of total RNA. Analytic protocols are summarized in the Online Data Supplement, and primer and probe sequences are reported in Online Table I .
Cell Activity Assays
Tube formation was evaluated in Matrigel-coated (BD Biosciences, San Jose, Calif) plates, and migration was evaluated with a modified Boyden's chamber (Neuro Probe, Inc, Gaithersburg, Md), as summarized in the Online Data Supplement. Migration under each condition was assayed in triplicate, and each experiment was performed at least three times. 
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Results
Gli3 mRNA Expression Is Impaired in Gli3 ؉/؊ Mice
To verify that Gli3 expression was reduced in Gli3-haploinsufficient (Gli3 ϩ/Ϫ ) mice and, consequently, that Gli3 ϩ/Ϫ mice were suitable for studying the role of Gli3 in adult animals, we compared Gli3 mRNA expression in WT and Gli3 ϩ/Ϫ mice. Gli3 mRNA expression was significantly lower (by Ͼ50%) in Gli3 ϩ/Ϫ mice (Online Figure I , A); however, histological examination of skeletal muscle (Online Figure I , B) and heart tissue (Online Figure I , C) harvested from WT and Gli3 ϩ/Ϫ mice revealed no apparent structural differences. Similarly, physiological assessments found no significant differences between WT and Gli3 ϩ/Ϫ mice in blood pressure, heart rate, LV volume, or LV ejection fraction (Online Figure I , D through G). Thus, Gli3 haploinsufficiency significantly reduced Gli3 expression, but the muscle tissue of Gli3 ϩ/Ϫ mice appeared normal, and Gli3 ϩ/Ϫ mice displayed no significant cardiovascular functional anomalies at baseline.
Gli3 Contributes to Ischemic Tissue Repair After MI
MI was induced in WT and Gli3
ϩ/Ϫ mice. In WT mice, Gli3 expression was 5-to 7-fold greater in the ischemic myocardium than in nonischemic myocardium during the two-week period after MI ( Figure 1A ). Gli3 was expressed by ECs in the ischemic zone ( Figure 1B ) and by cardiomyocytes in the border zone of infracted hearts ( Figure  1C ), but was not expressed by cardiomyocytes in the absence of infarction (Online Figure II) Figure 1D and 1E) . In hearts harvested 28 days after MI, fibrosis area was 1.7Ϯ5-fold greater (Pϭ0.007) in Gli3 ϩ/Ϫ mice than in WT mice ( Figure 1F and 1G), and capillary density was 30.14Ϯ11.23% (Pϭ0.0015) lower in the ischemic region and 28.29Ϯ8.49% (Pϭ0.0044) lower in the ischemic border zone (Figure 1H and 1I) . ϩ/Ϫ mice than in WT mice after MI. MI was surgically induced in Gli3 ϩ/Ϫ mice and their WT littermates. A, Gli3 mRNA expression was evaluated by quantitative RT-PCR and normalized to 18S rRNA expression in areas of ischemic and nonischemic myocardial tissue 1, 5, and 14 days after surgically induced MI. B, Heart cross-sections were stained with anti-Gli3 antibodies (green) (left) or triple stained with anti-Gli3 antibodies (green), anti-CD31 antibodies (red) to identify endothelial cells, and DAPI (blue) to identify nuclei (right). C, Heart cross-sections were stained with anti-Gli3 antibodies (red) (left) or triple stained with anti-Gli3 antibodies (red), anti-desmin antibodies (green) to identify cardiac muscle, and DAPI (blue) to identify nuclei (right). D and E, LV ejection fractions (D) and systolic and diastolic LV volumes (E) were evaluated by echocardiography 7, 14, and 28 days after MI in Gli3 ϩ/Ϫ (nϭ8) and WT (nϭ9) mice. F, Representative images of Masson trichrome-stained sections from the hearts of WT and Gli3 ϩ/Ϫ mice harvested 28 days after MI; regions of fibrosis appear blue. G, Fibrosis area was reported as the ratio of the length of fibrosis to the LV circumference. H, Representative images of anti-CD31-stained sections from the hearts of WT and Gli3 ϩ/Ϫ mice harvested 28 days after MI; ECs (ie, CD31 ϩ cells) appear reddish-brown. I, Capillary density was quantified as the number of CD31 ϩ vessels per HPF in the ischemic region and in the ischemic border zone. **PՅ0.01; *PՅ0.05.
Gli3 Contributes to Vascular Growth in Ischemic Hindlimbs
Our previous experiments 21 demonstrated that overexpression of Gli3 promotes neovascularization and perfusion in ischemic hindlimb muscle. To determine the role of endogenous Gli3 expression in response to ischemia, we evaluated the vascularity of ischemic hindlimb muscles from WT and Gli3 ϩ/Ϫ mice after surgically induced HLI. Seven and 14 days after HLI, Gli3 mRNA expression in ischemic muscle was approximately 3-fold lower in Gli3 ϩ/Ϫ mice than in WT mice (Figure 2A) , whereas mRNA expression of Gli2, Gli1, and of the Hh receptor Patched-1 (Ptch1) ( Figure 2B through 2D ) was preserved and did not differ significantly between strains. Seven, 14, and 28 days after HLI, capillary density ( Figure 2E and 2F) Figure 2G and 2H) ; however, the proportion of vessels that expressed ␣SMA did not differ significantly ( Figure 2I ), indicating that the development of vessels containing smooth muscle cells, which express Gli3, 21 may not be disproportionately impaired in Gli3 ϩ/Ϫ mice.
VEGF-Induced Angiogenesis Is Impaired in
The studies described thus far suggest that Gli3 participates in ischemia-induced angiogenesis. To determine whether Gli3 is required for the induction of vessel growth by angiogenic factors, we used the mouse corneal angiogenesis model and compared the growth of vessels toward VEGF-containing pellets implanted in the corneas of Gli3 ϩ/Ϫ and WT mice. 
E, Representative images of anti-CD31-stained sections from the ischemic limb muscle of WT and Gli3
ϩ/Ϫ mice harvested 14 days after HLI; ECs (ie, CD31 ϩ cells) appear reddish-brown. F, Capillary density was quantified as the number of CD31 ϩ vessels per HPF; nϭ8 WT and 9 Gli3 ϩ/Ϫ mice on day 7, nϭ7 in each group on day 14, and nϭ5 WT and 7 Gli3 ϩ/Ϫ mice on day 28. G, Representative images of antismooth muscle ␣-actin (anti-SMA)-stained sections from the ischemic limb muscle of WT and Gli3 ϩ/Ϫ mice harvested 14 days after HLI; smooth muscle cells (ie, SMA ϩ cells) appear reddish-brown. Smooth muscle-containing vessels were quantified as (H) the number of SMA ϩ vessels per HPF and (I) the proportion of vessels that contained smooth muscle. ***PՅ0.001; **PՅ0.01.
VEGF-induced angiogenesis was substantially impaired in
Gli3-deficient mice ( Figure 3A and 3B) ; the expression of Gli3 by ECs in the VEGF-induced vasculature was confirmed via double immunofluorescent staining for Gli3 and for expression of the EC marker von Willebrand factor ( Figure 3C ).
Gli3 Regulates Function and Gene Expression in ECs
The potential influence of Gli3 on EC function was assessed in vitro. Downregulation of Gli3 delayed tube formation ( Figure 4A ): 8 hours after seeding on Matrigel, total tube length was significantly shorter (Pϭ0.008) in HUVECs transfected with Gli3 siRNA (934Ϯ976 pixels/HPF) than in cells transfected with GFP siRNA (5261Ϯ2008 pixels/HPF). Gli3 overexpression via Ad-Gli3 transduction enhanced HUVEC migration ( Figure 4B ). mRNA microanalyses of HUVECs transduced with AdGli3 or Ad-LacZ identified several factors upregulated by Gli3 overexpression, including CXC-chemokine ligand (CXCL)1 (also known as growth-regulated oncogene ␣), CXCL2 (growth-regulated oncogene ␤), CXCL5, CC-motif ligand (Ccl)2 (monocyte chemotactic protein 1), interleukin (IL)-8 (CXCL8), and colony-stimulating factor 3 (granulocyte colony-stimulating factor) (Online Table II Figure III, E) ; notably, PD-ECGF expression was significantly lower (Pϭ0.002) in ischemic limb muscle harvested from Gli3 ϩ/Ϫ mice than in WT ischemic limb muscle on the seventh day after HLI (Figure 4H ).
We also investigated whether Gli3 overexpression influenced Gli-dependent transcription in ECs by evaluating luciferase activity in HUVECs transfected with a plasmid coding for Gli-BS-regulated luciferase expression. Overexpression of Gli3 did not significantly alter luciferase activity ( Figure 4I) , and similar experiments demonstrated that Gli3 overexpression does not modulate Gli1 or Ptch1 expression in HUVECs (data not shown).
Gli3 Activates the Akt Pathway and the Mitogen-Activated Protein Kinase-ERK1/2 Pathway
Because Hh signaling is known to activate the Akt and mitogen-activated protein kinase (MAPK)-ERK1/2 pathways in ECs, 29 -32 we performed experiments to determine whether these pathways are also activated by Gli3 overexpression.
Western blot analyses indicated that ERK1/2 phosphorylation is higher in ECs transduced with Ad-Gli3 than in Ad-LacZ-transduced HUVECs ( Figure 5A ), and when Gli3 expression was knocked down by transfection with Gli3 siRNA, the level of phosphorylated ERK1/2 declined both in the presence and absence of VEGF ( Figure 5B ). Gli3-transduced ECs also expressed markedly higher (25Ϯ3-fold) levels of c-Fos, a downstream target of the MAPK-ERK1/2 pathway, and Gli3-induced c-Fos upregulation was significantly lower in the presence of the MAPK-ERK1/2 inhibitor U0126 ( Figure 5C ), indicating that ERK1/2 activation contributes to the upregulation of c-Fos expression by Gli3.
Akt phosphorylation was also higher in Ad-Gli3-transduced HUVECs than in HUVECs transduced with Ad-LacZ ( Figure 5D ). To determine whether Gli3-induced Akt phosphorylation occurred upstream, downstream, or independently of ERK1/2 activation, phosphorylated Akt and ERK1/2 levels were measured in ECs transduced with AdGli3 and DN-Akt (a dominant-negative mutant of Akt) or in Ad-Gli3-transduced ECs cultured in the presence and absence of U0126. Gli3-induced ERK1/2 phosphorylation was impaired in ECs cotransduced with DN-Akt ( Figure 5E ), but Gli3-induced Akt phosphorylation was not affected by the presence of U0126 (Figure 5F ), providing evidence that the activation of ERK1/2 by Gli3 occurs downstream of Akt activation.
Gli3-Induced EC Migration Is Dependent on Both Akt and MAPK-ERK1/2
The role of Akt and ERK1/2 in Gli3-induced EC migration and gene expression was investigated in HUVECs transduced with Ad-Gli3 and DN-Akt or in Ad-Gli3-transduced HUVECs cultured in the presence and absence of U0126. Gli3-induced EC migration declined when cells were cotransduced with DN-Akt or cultured in the presence of U0126 ( Figure 5G ), indicating that the enhanced migration associated with Gli3 overexpression is dependent on both Akt and MAPK-ERK1/2 activation. DN-Akt cotransduction, but not U0126 exposure, inhibited Gli3-induced expression of CXCL1 ( Figure 5H ), CXCL2, IL-8, and Ccl2 (Online Figure  IV , A through C), and CXCL1 expression was also impaired in Ad-Gli3/DN-Akt-cotransduced cells cultured with U0126 (Online Figure IV, D) , which suggests that Akt, but not ERK1/2, mediates the upregulation of these genes by Gli3. In contrast, PD-ECGF expression in Ad-Gli3-transduced HUVECs was not significantly impaired by DN-Akt cotransduction or by the presence of U0126 (Figure 5I ), suggesting that Gli3-induced PD-ECGF expression occurs through an Akt-and ERK-independent mechanism.
Discussion
Very recently, we have shown that Gli3, a transcription factor targeted by Shh during Hh signaling, is strongly upregulated in the ischemic tissue of adult mammals and may have a favorable effect on myogenesis and angiogenesis after an ischemic insult. 21 The findings reported here confirm our previous results and are the first to indicate that endogenous Gli3 expression contributes to postnatal angiogenesis. Our in vivo experiments demonstrate that Gli3 haploinsufficiency impairs angiogenesis in both the MI and HLI models and in response to VEGF stimulation, and the impairment in angiogenesis worsened functional outcomes in ischemic animals. Collectively, our observations strongly suggest that Gli3 has an important role during angiogenesis in adult mammals and that Gli3 upregulation is required for normal neovascularization during ischemic tissue repair.
Our previous work demonstrated that Gli3 is expressed in the ECs of ischemic skeletal muscle. 21 The present studies extended our earlier findings by identifying Gli3 expression in cardiac ECs after MI, and we also showed that in vitro Gli3 expression regulates EC migration and tube formation. Other reports have identified similarities between the mechanisms involved in angiogenesis and axonal guidance, [33] [34] [35] which is also dependent on Gli3, and may lead to speculation about whether the regulation of EC activity by Gli3 could be considered analogous to the Gli3-dependent migration of olfactory neurons. 36,37 4 cells were seeded in the upper chamber of a modified Boyden chamber, and the lower chamber was filled with EBM-2 medium containing 1% fetal-bovine serum. Migration was quantified 8 hours after seeding by calculating the number of cells per HPF that had migrated to the lower chamber. The mRNA expression of CXCL1 (C), CXCL2 (D), Ccl2 (E), IL-8 (F), and PD-ECGF (G) was evaluated via quantitative RT-PCR and normalized to 18S rRNA expression. H, Seven days after surgically induced HLI, PD-ECGF mRNA expression in muscle harvested from the nonischemic and ischemic hindlimbs of WT and Gli3 ϩ/Ϫ mice was evaluated via quantitative RT-PCR and normalized to 18S rRNA expression; nϭ8 WT mice and 9 Gli3 ϩ/Ϫ mice. **PՅ0.01. I, HUVECs were cotransfected with 3 plasmids: (1) a plasmid coding for Gli-regulated BS luciferase expression (pGli-BS) or mutant Gli-regulated BS luciferase expression (pmGli-BS), (2) a plasmid coding for human Gli3 expression (phGli3) or a control pcDNA3 plasmid, and (3) a plasmid coding for LacZ expression. Forty-eight hours after transfection, luciferase activity in cell lysates was assayed and normalized to ␤-galactosidase activity.
Gli3 overexpression strongly upregulated the expression of several proangiogenic factors in ECs, including IL-8 and the CXCR2 ligands CXCL1 and CXCL2. 38 IL-8 promotes EC migration and tube formation, 39 whereas CXCR2 ligands have been associated with the mobilization of hematopoietic stem cells 40 and with endothelial progenitor cell recruitment, 41, 42 both of which contribute to ischemia-induced vascular regeneration. Gli3 overexpression in ECs also upregulated the expression of PD-ECGF, a strong proangiogenic factor that has been shown to promote neovascularization in MI 43 and HLI 44 models; furthermore, PD-ECGF expression in ischemic skeletal muscle was significantly lower in Gli3 ϩ/Ϫ mice than in WT mice. Thus, the impaired angiogenesis observed in Gli3 ϩ/Ϫ mice may evolve through a variety of mechanisms, including altered gene expression and EC activity or impaired stem cell mobilization and recruitment.
The transcriptional target of Gli3 and the potential cofactors that contribute to Gli3-mediated transcription have yet to be identified. The results from our gene-reporter assays suggest that Gli3 overexpression does not modulate Glidependent transcription in ECs, and the expression of Gli1 and Ptch1 mRNA were also unchanged. Gli3 overexpression enhanced ERK1/2 and Akt activity in ECs, but these effects may have occurred indirectly through the Gli3-induced upregulation of IL-8 and/or PD-ECGF. IL-8 has been shown to promote ERK1/2 phosphorylation in ECs, 39 whereas PD-ECGF promotes Akt phosphorylation in U937 cells 45 and Ccl2 and CXCL3 expression in HUVECs. 46 Future investigations are warranted to further characterize these mechanisms.
In conclusion, our observations indicate that Gli3 contributes to neovascularization under both ischemic and nonischemic conditions and provide the first evidence that Gli3 contributes to angiogenesis in adult mammals. Thus, Gli3 , and ERK1/2 phosphorylation (ERK1/2-P) was evaluated 48 hours later by Western blot. B, HUVECs were transfected with Gli3 siRNA or control GFP siRNA; 48 hours after transfection, cells were treated with or without 50 ng/mL VEGF for 5 minutes, then ERK1/2 phosphorylation was evaluated by Western blot. C and D, HUVECs were transduced with AdGli3 or AdLacZ. C, Twenty-four hours after transduction, cells were incubated with 10 mol/L U0126 (MAPK-ERK1/2 inhibitor) or dimethyl sulfoxide (vehicle) for 24 hours; then, c-Fos mRNA expression was evaluated via quantitative RT-PCR and normalized to 18S rRNA expression. D, Forty-eight hours after transduction, Akt phosphorylation (Akt-P) was evaluated by Western blot. E, HUVECs were cotransduced with AdLacZ or AdGli3 and AdLacZ or an adenoviral vector coding for a dominant-negative Akt mutant (DN-Akt). ERK1/2 phosphorylation was evaluated 48 hours later by Western blot. F, HUVECs were transduced with AdGli3 or AdLacZ; 24 hours after transduction, cells were incubated with 10 mol/L U0126 or dimethyl sulfoxide (vehicle) for 24 hours; then, Akt phosphorylation was evaluated by Western blot. G through I, AdLacZ-and AdGli3-transduced HUVECs were incubated with or without 10 mol/L U0126 for 24 hours or cotransduced with DN-Akt. G, Cells (5ϫ10 4 ) were seeded in the upper chamber of a modified Boyden chamber, and the lower chamber was filled with EBM-2 medium containing 1% FBS. Migration was quantified 8 hours after seeding by calculating the number of cells per HPF that had migrated to the lower chamber. H and I, The mRNA expression of CXCL1 (H) and PD-ECGF (I) was evaluated via quantitative RT-PCR and normalized to 18S rRNA expression. ***PՅ0.001.
